HMOX1 and chronic obstructive pulmonary disease: However, during COPD progression, pulmonary HO-1 expression significantly increases, leading to abnormal cerebral HO-1 accumulation via Exos-mediated trans-barrier transport—as confirmed by Exos tracking experiments showing fluorescently labeled Exos penetrating the BBB within 24 h of tail vein injection.